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Abstract
Background: Congenital human cytomegalovirus (HCMV) infections can result in CNS abnormalities in newborn
babies including vision loss, mental retardation, motor deficits, seizures, and hearing loss. Brain pericytes play an
essential role in the development and function of the blood–brain barrier yet their unique role in HCMV
dissemination and neuropathlogy has not been reported.
Methods: Primary human brain vascular pericytes were exposed to a primary clinical isolate of HCMV designated
‘SBCMV’. Infectivity was analyzed by microscopy, immunofluorescence, Western blot, and qRT-PCR. Microarrays were
performed to identify proinflammatory cytokines upregulated after SBCMV exposure, and the results validated by
real-time quantitative polymerase chain reaction (qPCR) methodology. In situ cytokine expression of pericytes after
exposure to HCMV was examined by ELISA and in vivo evidence of HCMV infection of brain pericytes was shown
by dual-labeled immunohistochemistry.
Results: HCMV-infected human brain vascular pericytes as evidenced by several markers. Using a clinical isolate of
HCMV (SBCMV), microscopy of infected pericytes showed virion production and typical cytomegalic cytopathology.
This finding was confirmed by the expression of major immediate early and late virion proteins and by the
presence of HCMV mRNA. Brain pericytes were fully permissive for CMV lytic replication after 72 to 96 hours in
culture compared to human astrocytes or human brain microvascular endothelial cells (BMVEC). However, temporal
transcriptional expression of pp65 virion protein after SBCMV infection was lower than that seen with the HCMV
Towne laboratory strain. Using RT-PCR and dual-labeled immunofluorescence, proinflammatory cytokines
CXCL8/IL-8, CXCL11/ITAC, and CCL5/Rantes were upregulated in SBCMV-infected cells, as were tumor necrosis
factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta), and interleukin-6 (IL-6). Pericytes exposed to SBCMV
elicited higher levels of IL-6 compared to both mock-infected as well as heat-killed virus controls. A 6.6-fold
induction of IL-6 and no induction TNF-alpha was observed in SBCMV-infected cell supernatants at 24 hours
postinfection. Using archival brain tissue from a patient coinfected with HCMV and HIV, we also found
evidence of HCMV infection of pericytes using dual-label immunohistochemistry, as monitored by NG2
proteoglycan staining.
Conclusion: HCMV lytic infection of primary human brain pericytes suggests that pericytes contribute to both
virus dissemination in the CNS as well as neuroinflammation.
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Background
Human cytomegalovirus (HCMV) is a ubiquitous patho-
gen and is the most common infectious cause of con-
genital disease [1-4]. Congenital infections caused by
HCMV represent the leading infectious cause of mental
retardation and deafness in children [5,6]. Other abnor-
malities in newborns include vision loss, motor deficits,
seizures, and sensorineural hearing loss [7-9]. With only
10 to 15% of children presenting with symptomatic
disease at birth, HCMV can also result in long-term
progressive neuropathology in children who are asymp-
tomatic at birth. It is estimated that approximately 8,000
children are affected each year in the United States with
some form of neuropathology associated with a cyto-
megalovirus (CMV) congenital infection [7]. In addition,
HCMV, a common opportunistic infection in patients
with HIV/AIDS [10], is often found in brain tissue from
these patients [11] where it can be associated with
cytomegalovirus-induced encephalitis [12,13].
The blood–brain barrier (BBB) interfaces the periph-
eral circulation and the central nervous system (CNS)
allowing nutrients into the CNS and preventing blood-
borne pathogens from harming the brain. This barrier is
an elaborate network of tight junctions (TJ) between ca-
pillary endothelial cells that lack fenestrae and have a
reduced capacity for pinocytosis [14,15]. The TJ of the
capillary endothelium is supported by astrocytic endfeet
and pericytes. Cerebral vascular pericytes (CNS peri-
cytes) have been shown to enhance TJ barrier function,
stimulate expression of TJ proteins and reduce the para-
cellular permeability of the capillary endothelium [16-
19]. Pericytes are adult multipotent, contractile and mi-
gratory stem cells [20,21] that surround capillaries and
actively communicate with other cells of the neurovas-
culature, including endothelial cells, astrocytes and neu-
rons. Completely surrounded by a basal lamina, they
also contribute to the deposition of the basal lamina
during vascular development and angiogenesis [22].
Although a critical cellular component for the develop-
ment and function of the BBB, the role of pericytes in
HCMV infection and dissemination has largely been
ignored [23]. Rather, to date, astrocytes and brain micro-
vascular endothelial cells (BMVEC) cells have been
implicated as cell types that support HCMV dissemin-
ation at the blood–brain barrier level [7].
To our knowledge, no studies have reported on the
interaction between human cytomegalovirus and brain
vascular pericytes. However in 1990, Price et al. [24]
demonstrated murine CMV (MCMV) infection of peri-
cytes in brown and white adipose tissue of young adult
infected mice. These mice later developed viral-induced
inflammatory lesions in peripancreatic and salivary gland
adipose tissues. In the present study, we investigated the
infectivity of human brain vascular pericytes by HCMV
using a primary isolate from a child with disseminated
HCMV disease. Infection was determined by monitoring
pericytes for HCMV cytopathology using standard bio-
chemical assays for viral proteins and viral mRNA.
Proinflammatory cytokines expressed in exposed peri-
cytes were identified by microarrays and confirmed by
dual-labeled immunofluorescence and real-time PCR
(qRT-PCR).
This is the first report to date that investigates the in-
fectivity of human brain pericytes for HCMV and their
role in viral dissemination in the CNS. It supports the
postulate that pericytes are more permissive for CMV
lytic replication compared to BMVEC or astrocytes, and
that pericytes could serve as amplification reservoirs for
HCMV. Finally, pericyte exposure to HCMV induced




The primary isolate (termed SBCMV) was provided by
Dr. Ravit Arav-Boger, Johns Hopkins University, and
obtained from the urine of a congenitally infected infant
with disseminated HCMV disease. Institutional review
board (IRB) exemption for the use of this isolate was
given by Johns Hopkins Hospital. Primary human brain
vascular pericytes and astrocytes were obtained from
Cell Systems (Kirkland, WA, USA). Primary BMVEC
cells were a kind gift from Dr. Milan Fiala (UCLA, Los
Angeles, CA, USA) [25]. All cells were maintained at
low passage in complete pericyte medium from ScienCell
Corporation (Carlsbad, CA, USA). Cells were trypsinized
and plated in uncoated 100 cm2 dishes or uncoated
4.2 cm2/well glass chamber slides at a density 1 × 106 and
2.5 × 105 cells per dish and well, respectively. Heat-killed
SBCMV was prepared by heating the viral inoculum to
65°C for 30 minutes in a water bath [26].
Microarray analysis
The GeneChip Human Genome U133 Plus 2.0 array
(Affymetrix, Santa Clara, CA, USA) with complete cover-
age of the human genome containing over 47,000 tran-
scripts was used to identify gene expression changes in
primary human brain vascular pericytes three days postin-
fection. Several proinflammatory cytokines that were
upregulated after SBCMV infection were selected for
further study. A subgroup of genes identified as having
the highest fold transcription levels associated with neu-
roinflammation were selected for qRT-PCR analysis.
Cytomegalovirus infection of pericytes and RNA isolation
Pericytes were infected with SBCMV at a multiplicity of
infection (MOI) of 0.1 and virus adsorption was allowed
for three hours, then the inoculum was removed and
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replaced with fresh media. Uninfected pericytes were used
as mock-infected controls. Cultures were examined daily
for evidence of cytopathology and at three days postinfec-
tion, cells were harvested, pelleted, and total RNA
extracted at a density of 3 × 106 cells using an RNeasy
Mini Kit (Qiagen, Valencia, CA, USA). Extracted RNA
was treated with 0.4 units/ml of RNase-free DNase (Qia-
gen, Valencia, CA, USA). RNA purity was first determined
by spectrophotometric analysis, then resuspended in
RNase-free water at a concentration of 200 ng/μl and
stored at −80°C. RNA quality was assessed using an Agi-
lent 2100 bioanalyzer (Agilent Technologies, Santa Clara,
CA, USA).
Electron microscopy
Three days postinfection, pericytes were washed twice in
sodium cacodylate buffer pH 7.4, fixed in 2.5% glutaral-
dehyde for one hour and held at 4°C for an additional
twenty-four hours. Monolayers were rinsed twice with
0.1 M sodium cacodylate buffer (pH 7.4), fixed in 1% os-
mium tetraoxide for one hour, washed twice for five
minutes in cacodylate buffer and dehydrated in graded
ethanol. HCMV-infected pericytes were pelleted for 10
minutes at 1500 rpm in a Sorvall Legend RT centrifuge
(ThermoFisher Scientific, Waltham, MA, USA). Pellets
were embedded in spur resin, sectioned for standard
electron microscopy (EM) analysis and visualized on a
Phillips CM12 electron microscope (Phillips Research,
Eindhoven, The Netherlands).
Western blot
Cell extracts were prepared using RIPA lysis buffer
[50 mM Tris pH 7.5, 150 mM NaCl, 2 mM ethylenedia-
minetetraacetic acid (EDTA) pH 8.0, 1% NP40, 0.5% so-
dium deoxycholate, 0.1% sodium dodecyl sulfate (SDS),
and proteinase inhibitor]. Lysates were placed on ice for
30 minutes and then clarified by centrifugation. Total
protein was measured by bicinchoninic acid (BCA) assay
(Pierce; ThermoFisher Scientific, Waltham, MA, USA).
Fifteen μg of protein lysates from paired, mock and
infected samples were fractionated in 4 to 20% SDS-
PAGE gels, transferred to nitrocellulose membranes,
blocked with 5% milk, 0.1% TBST (0.1% Tween 20, 20
mM Tris, 150 mM NaCl) and incubated at 4°C overnight
with a monoclonal antibody to either major immediate
early gene (MIE) (mAb 810 recognizes MIE IE1 and IE2,
(Millipore, Temecula, CA, USA) or to human cyto-
megalovirus phosphorylated envelope protein expressed
at late times during virus replication (pp65) (Vector
Laboratories, Burlingame, CA, USA), both at a 1:2000
dilution. Membranes were washed five times in 0.1%
TBST and incubated for one hour followed by incuba-
tion with a secondary antibody donkey anti-mouse per-
oxidase conjugate (Santa Cruz Biotech, Santa Cruz, CA,
USA) at a dilution of 1:10,000. Immunoreactive bands
were detected with SuperSignal West Dura Extended
Substrate (Pierce; ThermoFisher Scientific, Waltham,
MA, USA) following exposure to X-ray film.
RT-PCR
Total RNA was extracted from SBCMV-infected pericytes
and controls using a Qiagen RNeasy Mini Kit (Qiagen,
Valencia, CA, USA). RNA was DNase-treated prior to
elution on the column according to the manufacturer’s
recommendations. Messenger RNA in 1 μg of each sam-
ple was primed using oligo-dT and reverse transcribed
with a high-capacity cDNA reverse transcription kit
(Applied Biosystems, Foster City, CA, USA). Gene-specific
primer pairs included C chemokine (C-C motif ) ligand
5/Rantes (CCL5/Rantes), chemokine (C-X-C motif) ligand
11/I-TAC (CXCL11/I-TAC), and (CXCL8/IL-8) and 10 to
200 ng of cDNA for RT-PCR amplification, using
PuReTaq Ready-To-Go PCR beads (GE Healthcare,
Buckinghamshire, UK). PCR was carried out in a MJ
Mini thermal cycler (Bio-Rad Laboratories, Hercules,
CA, USA) in a final volume of 25 μl. The cycling
protocol used was 95°C for five minutes, 55°C for
thirty seconds, and 72°C for one minute for thirty-six
cycles, with a final extension at 72°C for ten minutes.
PCR products were electrophoresed in 1.5% agarose
and DNA bands visualized by ethidium bromide. Primers
for RT-PCR amplification were designated as: HCMV MIE
1 forward 5′-CCAAGCGGCCTCTGATAACCAAGCC-3′,
reverse 5′-CAGCACCATCCTCCTCTTCCTCTGG3′
(exon 4, 435 bp); radical S-adenosyl methionine domain-
containing protein 2 (RSAD2) forward 5′-CTTTGTGCT
GCCCCTTGAGGAA- 3′, reverse 5′CTCTCCCGGAT
CAGGCTTCCA3′ (256 bp); CXCL8/IL-8 forward 5′-TG
GGTGCAGAGGGTTGTG-3′, reverse 5′-CAGACTAGG
GTTGCCAGATTTA-3′ (532 bp); CXCL11/I-TAC forward
5′- TTAAACAAACATGAGTGTGAAGGG-3′, reverse 5′-
CGTTGTCCTTTATTTTCTTTCAGG-3 (228 bp); and
CCL5/Rantes forward 5′- GGCAGCCCTCGCTGTCATC
CTCA-3′, reverse 5′ –CTTGATGTGGGCACGGGGCA
GTG-3′. Gyceralaldehyde phosphate dehydrogenase
(GAPDH) forward 5′- TGATGACATCAAGAAGGTG
GTGAA-3′, reverse 5′-TCCTTGGAGGCCATGTGGGC
CAT-3′ (256 bp) was amplified in mock and infected cells
as a loading and quality control.
Real-time qPCR
Real-time PCR was performed in 96 well optical plates
(Sorenson Bioscience, Inc., Salt Lake City, UT, USA)
with cDNA using the MyiQ Single-Color Real-Time
PCR Detection System (Bio-Rad Laboratories, Hercules,
CA, USA) in 25 μl reaction volumes. A master mix was
made according to manufacturer’s instructions using
SYBR green supermix (Bio-Rad Laboratories, Hercules,
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CA, USA) or VeriQuest master mix (Affymetrix, Santa
Clara, CA, USA) for amplification of high GC-content
cDNAs. Forward and reverse primers were used at a con-
centration of 250 nM per well, made in RNase/DNase-free
H2O. Primer sequences for qPCR were as follows: TNF-
alpha forward 5′- CAGAGGGAAGAGTTCCCCAG -3′,
reverse 5′-CCTTGGTCTGGTAGGAGACG- 3′; IL-1beta
forward 5′-CAAATTCGGTACATCCTCGAC-3′, reverse
5′- GTCAGGGGTGGTTATTGCATC-3′); and IL-6
forward 5′- AAACAGATGAAGTGCTCCTTCCAGG-3′,
reverse 5-TGGAGAACACCACTTGTTGCTCCA- 3′. The
cDNAs from mock-infected and SBCMV-infected pericytes
were diluted 1:3 using RNase/DNase-free H2O; 3 μl of this
dilution was added to each well, and control wells substi-
tuted water for cDNA. The cycling sequence included 95°C
for three minutes, 95°C for fifteen seconds, 60°C for one
minute, 95°C for one minute, 55°C for one minute, and
55°C for thirty seconds for eighty-one total cycles. A
GAPDH primer set was included for normalization. Data
analysis was performed using Bio-Rad iQ5 optical system
software version 2.0.
Immunofluorescence
Chamber slides containing either infected or uninfected
cells were washed twice with phosphate buffer saline
(PBS) pH 7.4, air dried, and fixed in absolute methanol
for 10 minutes. Cells were air dried for fifteen minutes,
hydrated in Tris saline (pH 7.4) for five minutes, and
then incubated for one hour with monoclonal antibodies
to the HCMV MIE at a 1:50 dilution (MIE, mAb 810,
Millipore, Temecula, CA, USA) or the HCMV tegument
protein pp65 (UL83) at 1:50 (Vector Laboratories,
Burlingame, CA, USA). Dual-labeled immunofluorescence
was performed using a mouse monoclonal to HCMV MIE
and goat polyclonal antibodies at 1:100 dilution to human
CXCL8/IL-8, CXCL11/I-TAC, and CCL5/Rantes pur-
chased from R&D Systems (Minneapolis, MN, USA). Glial
fibrillary acid protein (GFAP), (Millipore, Temecula, CA,
USA), von Willebrand factor (VWF) (Millipore, Temecula,
CA, USA) and neuron-glial antigen 2 (NG2) proteogylcan
(Santa Cruz Biotech, Santa Cruz, CA, USA) were used at
a 1:50 dilution for immunofluorescent staining of astro-
cytes, brain microvascular endothelial cells (BMVEC) and
pericytes, respectively. Cells were washed three times with
Tris saline and then incubated at 37°C for thirty minutes
with a combination of secondary donkey anti-mouse
Immunoglobulin G (IgG) antibodies conjugated with
rhodamine isothiocyanate (RITC), and donkey anti-goat
antibody conjugated with fluroescein isothiocyanate (FITC),
(Jackson ImmunoResearch, West Grove, PA, USA) at a
1:100 dilution in PBS. Cells were washed another three
times in Tris saline and mounted with Vectashield mount-
ing media (Burlingame, CA, USA) containing 1.5 μg/ml of
4′,6-diamidino-2-phenylindole (DAPI). Fluorescence was
Figure 1 Primary brain vascular pericytes. Phase contrast images of: (A) an uninfected subconfluent monolayer of primary brain vascular
pericytes, (B) a confluent monolayer of brain vascular pericytes, and (C) pericytes 72 hours after infection with SBCMV. Immunofluorescence
staining of SBCMV-infected pericytes for (D) HCMV MIE protein and (E) pp65 late protein. (F) TEM of SBCMV-infected pericytes showing HCMV
virions in the cytoplasm (see arrow). With the exception of the TEM, images were taken on a Nikon TE2000S microscope (200x magnification).
HCMV, human cytomegalovirus; MIE, major immediate early protein; SBCMV, primary HCMV isolate from a patient; TEM, transmission electron
microscopy.
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Figure 2 (See legend on next page.)
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photographed with a Nikon TE 2000 S fluorescent micro-
scope mounted with a charge-coupled device (CCD) cam-
era (Nikon, Tokyo, Japan).
Human cytokine ELISA
The effects of HCMV exposure on pericyte expression
of cytokines was measured with a human angiogenesis
cytokine ELISA assay kit, profiling angiogenic cytokines
(Signosis Sunnyvale, CA, USA). Mock-infected, pericytes
exposed to heat-killed virus and SBCMV-infected peri-
cytes were plated at a density of 5 x 105 cells in 10 cm
dishes and grown to 90% confluence. Cell supernatants
were then assayed for TNF-alpha, IL-6 and tumor
growth factor-beta (TGF-beta), according to the manu-
facturer’s protocol. Quantitative analysis of IL-6 and
TNF-alpha secreted from SBCMV-infected pericyte super-
natants after 24 hours were monitored using human TNF-
alpha and human IL-6 cytokine ELISA assays from Signo-
sis according to the manufacturer’s protocol.
Immunohistochemistry
Dual-labeled immunohistochemistry (IHC) was per-
formed as previously described [27] Archival brain tissue
from an HIV-infected patient was obtained from the
Texas Repository for AIDS Neuropathogenesis Research
(Galveston, TX, USA). Specimen use was HIPPA compli-
ant and approved by the Meharry Medical College IRB.
Brain tissue was histologically identified as positive for
HIV and HCMV. Tissue was mounted on chemate
slides, paraffin embedded and dual stained by IHC for
HCMV MIE in combination with the pericyte marker
NG2 proteoglycan (Abcam, Cambridge, MA, USA) [28].
Statistical analysis
Experiments presented in this study were performed in
triplicate (CMV-exposed brain pericytes, astrocytes and
BMVEC cell pellets were used for qRT-PCR, while paral-
lel supernatants were pooled for the ELISA assay).
Quantitative real-time PCR experiments were replicated
three times and normalized to GAPDH.
Results
Cytomegalovirus infection of pericytes
Primary brain vascular pericytes exhibited characteris-
tic long extensions of cytoplasm in subconfluent cul-
tures (Figure 1A), appeared fibroblastic when confluent
(Figure 1B), and had typical cytomegalic cytopathology
three days postinfection with the SBCMV clinical isolate
(Figure 1C). Pericytes supported full lytic replication of
SBCMV, as more than 80% of cells were infected as
demonstrated by the production of HCMV MIE 1 and 2
and the viral tegument protein pp65 (Figure 1D, E). These
results were performed in triplicate using the same viral
inoculum. Transmission electron microscopy (TEM) ana-
lysis revealed typical cytomegalovirus virions in SBCMV-
infected pericytes three days postinfection (Figure 1F).
Cytomegalovirus protein expression in pericytes and
upregulation of proinflammatory cytokine proteins and
mRNA
Using Western blots, we observed HCMV MIE 1, 2 and
the pp65 late virion protein expression in pericytes
infected with SBCMV compared to mock-infected con-
trol cells (Figure 2A). Temporal expression of the gene
encoding HCMV pp65 virion protein was determined by
qRT-PCR in pericytes infected with either the SBCMV
isolate or the Towne lab HCMV strain after 12, 24, 48,
72, or 96 hours of incubation. With the SBCMV clinical
isolate, we observed marginal expression of pp65 mRNA
in infected pericytes beginning at 72 hours and a 19.4-
fold increase in pp65 mRNA at 96 hours postinfection
compared to mock-infected controls (Figure 2B). With
the Towne laboratory strain of HCMV we observed a
34-fold, 1,011-fold and a 4,026-fold increase in pp65
mRNA in infected pericytes at 48, 72, and 96 hours re-
spectively (Figure 2B). By semi-quantitative real-time
PCR we observed upregulation of IL-8, CXCL11/I-TAC,
and CCL5/Rantes in SBCMV-infected pericytes compared
to mock-infected control cells (Figure 2C). Transcriptional
analysis by semi-quantitative RT-PCR revealed HCMV
MIE 1 transcripts expressed in infected cells but not con-
trols (Figure 2C). Using RT-PCR amplifications for proin-
flammatory cytokines CXCL8/IL-8, CXCL11/I-TAC, and
(See figure on previous page.)
Figure 2 Protein expression in mock- and SBCMV-infected brain pericytes. (A) Western blot showing expression of HCMV MIE and pp65
virion proteins in pericytes infected with SBCMV for 72 hours. Actin was the loading control. (B) Temporal expression of HCMV pp65 virion
protein by real-time PCR in infected pericytes (SBCMV or Towne CMV) at 12, 24, 48, 72, and 96 hours postinfection. (C) Semi-quantitative RT-PCR
for HCMV MIE, GAPDH, CXCL8/IL-8, RSAD2, CXCL11/I-TAC and CCL5/Rantes (72-hour exposure). GAPDH was the loading control. (D) Real time
RT-PCR analysis for CCL5/Rantes, CXCL11/I-TAC, and CXCL8/IL-8 in pericytes 72 hours after SBCMV infection. This experiment was replicated three
times, and amplifications were performed in triplicate and normalized to GAPDH. CCL5/Rantes, chemokine (C-C motif) ligand 5/Rantes;
CXCL8/IL-8, blood–brain barrier; CXCL11/I-TAC, chemokine (C-X-C motif) ligand 11/I-TAC; GAPDH, gyceralaldehyde phosphate dehydrogenase;
HCVM, human cytomegalovirus; MIE, major immediate early protein: pp65, human cytomegalovirus phosphorylated envelop protein expressed at
late times during virus replication; RSAD2, radical S-adenosyl methionine domain-containing protein 2; RT-PCR, reverse transcription polymerase
chain reaction; SBCMV, primary HCMV isolate from a patient.
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A.
Dual LabelI FA on SBCMV Infected Pericyte sex pressing CMVIE1 and IL-8
MergedDAPI
All 200X total magnification
Human IL-8 FITC GoatHCMVIE - 1 Rhodamine Mab
B.
IFA on SBCMV Infected Pericytes Expressing HCMV MIE and CXCL11/I-TAC






IFA on SBCMV Infected Pericytes Expressing HCMV MIE and CCL-5 / Rantes
Human CCL-5 FITC Goat
Merged
HCMV MIE-1 Rhodamine Mab
DAPI
All 600X magnification
Figure 3 (See legend on next page.)
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CCL5/Rantes, we observed increased mRNA expression for
all three cytokines in SBCMV-infected pericytes (Figure 2C).
RSAD2 [29,30] was amplified as a control for genes specif-
ically upregulated after HCMV infection (Figure 2B). Quan-
titative real-time PCR analysis indicated that CCL5/Rantes,
CXCL11/I-TAC, CXCL8/IL-8 were upregulated after
SBCMV infection by a factor of 3.2-fold, 3.2-fold
and 44.7-fold, respectively, when normalized to transcrip-
tion levels in mock-infected cells [31-33] (Figure 2D).
Cellular upregulation of proinflammatory cytokines in
SBCMV-infected brain pericytes
After performing dual-labeled immunofluorescence for
the HCMV MIE nuclear antigen (RITC-labeled) and the
respective chemokine (FITC-labeled), we observed an in-
crease in cellular expression of IL-8, CXCL11, and
Rantes FITC, stained with donkey anti-goat antibodies
(Figure 3A, B, C). IL-1 beta (25-fold) and IL-6 (8-fold)
were also upregulated in SBCMV-infected pericytes by
qRT-PCR when compared to mock-infected control cells
(Figure 4). We observed statistical significance for IL-1
beta and IL-6 but not TNF-alpha transcription.
Pericytes are more permissive for SBCMV infection than
astrocytes and brain microvascular endothelial cells
Cultured human cortical astrocytes, BMVEC and peri-
cytes were stained positive for representative markers
glial fibrillary acidic protein (GFAP), von Willebrand fac-
tor (vWF) and NG2 proteoglycan, respectively (Figure 5A).
All three cell types were separately exposed to SBCMV for
72 hours (Figure 5B). Only pericytes cultures developed
cytomegalic cytopathology compared to astrocytes and
BMVEC (Figure 5B). Astrocytes and BMVEC cells
exposed to SBCMV appeared no different than
mock-infected cells, in that there was no evidence of
infection by microscopy (Figure 5B). We then wanted to
examine for evidence of viral lytic gene expression using
qPCR. mRNA expression for the CMV late virion protein
pp65 revealed that pericytes expressed pp65 mRNA at a
very high level compared to controls, with no detection




























Real-time RT-PCR Analysis for Proinflammatory
SBCMV Infection
Figure 4 Real time RT-PCR analysis for proinflammatory cytokines. Cytokine IL-1 beta, IL-6 and TNF-alpha expression in pericytes 72 hours
after SBCMV infection. This experiment was replicated three times, and amplifications were performed in triplicate and normalized to GAPDH.
GAPDH, gyceralaldehyde phosphate dehydrogenase; RT-PCR, reverse transcription polymerase chain reaction; SBCMV, primary HCMV isolate from
a patient.
(See figure on previous page.)
Figure 3 Dual-labeled immunofluorescent staining of SBCMV-infected pericytes showing colocalization (merged images) of proteins.
(A) Infected pericytes expressing MIE proteins and CXCL8/IL-8. (B) Infected pericytes expressing MIE proteins and CXCL11/I-TAC. (C) Infected
pericytes expressing MIE proteins and CCL5/Rantes. CCL5/Rantes, chemokine (C-C motif) ligand 5/Rantes; CXCL8/IL-8, blood–brain barrier;
CXCL11/I-TAC, chemokine (C-X-C motif) ligand 11/I-TAC; MIE. major immediate early protein; SBCMV, primary HCMV isolate from a patient.
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above background expression for astrocytes and BMVEC
cells (Figure 6). We then wanted to examine the expres-
sion of proinflammatory cytokines elicited by pericytes
after SBCMV exposure. Utilizing a human cytokine ELISA
assay with supernatants from SBCMV and heat-killed
virus exposed pericytes 24 hours after exposure, we
observed a marginal increase in TNF-alpha in pericytes







SBCMV infected 72 hours
Mock Infected Control cells
Blood-Brain Barrier Cells Infected with SBCMV
Human Cortex Astrocytes Human Cortex BMVEC Human Cortex Pericytes
nacylgoetorP2GNnoisserpxEPAFG Von Willebrand factor
Cellular Components of the TRI-CELL Culture Model of the Blood-Brain Barrier
Figure 5 CMV infection of blood–brain barrier cellular components. Human brain cortical astrocytes, BMVEC and pericytes representing the
major cellular components of the blood–brain barrier were infected with SBCMV. Cells cultivated to 50% confluence were stained with
representative markers. (A) Astrocytes were stained for glial fibillary acidic protein (GFAP), BMVEC for von Willebrand factor (vWF) and brain
pericytes with NG2 proteoglycan antibodies. (B) All three cell types were infected with SBCMV for 72 hours. BMVEC, brain microvascular
endothelial cells; GFAP, glial fibrillary acidic protein; NG2, neuron-glial antigen 2; SBCMV, primary HCMV isolate from a patient; vWF, von
Willebrand factor.
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In addition, we also showed an increase in IL-6 in peri-
cytes exposed to both SBCMV and heat-killed virus, al-
though a higher level of IL-6 was observed in those
pericytes exposed to untreated SBCMV compared to heat-
killed virus. No significant change in TGF-beta levels was
observed in 24-hour virus-exposed pericytes when com-
pared to uninfected control cells (Figure 7A). Analysis of
TNF-alpha and IL-6 secreted from pericytes in infected
cell supernatants showed no induction of TNF-alpha
compared to mock-infected controls (Figure 7B) and a
6.6-fold increase in IL-6 protein levels was observed in
SBCMV-infected cell supernatants when compared to
controls levels (Figure 7C).
Cytomegalovirus infects pericytes in vivo
Single and dual IHC staining was performed on archival
brain tissue from an HIV-infected patient with HCMV-
disseminated CNS disease. We demonstrated the pres-
ence of HIV by single label IHC (Figure 8A, B) using
HIV group-specific antigen (Gag) antibodies, and for
HCMV in (Figure 8C, D) using virus major immediate
early gene (MIE) antibodies. To demonstrate CMV in-
fection of pericytes in archival brain tissue, we per-
formed dual-labeled IHC using antibodies for both NG2
proteoglycan, a cytoplasmic marker for pericytes [27, 28],
and for HCMV MIE, a nuclear marker to detect CMV-
infected pericytes. We demonstrated dual cytoplasmic
(NG2 proteoglycan, brown) and nuclear staining (HCMV
MIE, red) in CMV-infected archival brain tissue. These
results support our in vitro proof of concept data indicat-
ing that human brain vascular pericytes support CMV
infection.
Discussion
The role of brain vascular pericytes regarding CMV
infectivity and virus dissemination into the CNS is
unknown. The role of pericytes in HCMV-induced
neuroinflammation is also unknown. Determining the
mechanisms involved in the dissemination of CMV in the
CNS is critical for understanding how CMV infection in
utero may cause neurodevelopmental abnormalities in
children [34,35]. In this study, we found that pericytes are
highly permissive for HCMV lytic replication using a low-
passaged clinical isolate of human CMV (SBCMV). We
observed typical CMV cytopathology and staining patterns
for MIE 1, 2 and the late viral protein pp65 as well as vir-
ion production consistent with lytic replication in permis-
sive cells [4].
Figure 6 Expression of SBCMV pp65 virion protein mRNA by pericytes, BMVEC and astrocytes. Real-time PCR analysis of pp65 late virion
protein mRNA levels in SBCMV-infected pericytes, BMVEC and astrocytes. cDNA was prepared from total RNA isolated at 24 and 96 hours
postinfection along with RNA from mock-infected control cells. Black bars indicate fold transcription for SBCMV-infected pericytes, BMVEC and
astrocytes. This experiment was replicated three times and normalized to GAPDH. BMVEC, brain microvascular endothelial cells; GAPDH,
gyceralaldehyde phosphate dehydrogenase; pp65, human cytomegalovirus phosphorylated envelop protein expressed at late times during virus
replication; PCR, polymerase chain reaction; SBCMV, primary HCMV isolate from a patient.
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We felt that it was essential to use a low-passaged clin-
ical isolate of HCMV in these studies because laboratory-
adapted strains of HCMV are passaged in culture and
accumulate deletions as well as genome rearrangements
for growth adaptation in fibroblasts, which are routinely
used to cultivate CMV in the laboratory [36-38]. There-
fore, when we observed a lower level of viral replication
kinetics in pericytes for the SBCMV isolate compared to
the Towne lab CMV strain, we attributed this finding to
the lack of adaptation of a virus that was only passaged in
culture twice after initial isolation (Figure 2B). Studies by
Cha et al. in 1996 [36] showed that human CMV clinical
isolates carry up to 19 genes not found in the highly pas-
saged laboratory strains of HCMV. These genome differ-
ences may account for the differences in virulence and
tissue tropism [39,40].
The loss of HCMV UL128-to-UL150 loci, and specific-
ally the UL128, UL130 and UL131 gene cluster observed
in the laboratory-adapted strains of HCMV like AD169
and Towne that are important for virus infection and
spread in epithelial and endothelial cells, due to exten-
sive passage in fibroblasts, appears not to be required for
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Figure 7 Human cytokine ELISA assay. Analysis of human cytokines after SBCMV infection of brain vascular pericytes. A human cytokine ELISA
assay was performed on supernatants from SBCMV-infected pericytes, SBCMV heat-killed pericytes and mock-infected cells. Shown are the relative
amounts of TNF-alpha, IL-6 and TGF-beta in cell culture supernatants elicited 24 hours postexposure (A). Quantitative measurements IL-6 and
TNF-alpha secreted from pericytes in infected cell supernatants 24 hours postinfection was based on optical density utilizing a standard curve for
human IL-6 (B) and human TNF-alpha (C). Analysis was performed in triplicate and values were expressed in picograms/milliliter. IL, interleukin;
SBCMV, primary HCMV isolate from a patient; TGF-beta, tumor growth factor-beta; TNF-alpha, tumor necrosis factor-alpha.
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A comparative analysis of SBCMV infectivity in vitro
with other cellular components of the BBB (astrocytes
and BMVEC) suggests that pericytes are the most per-
missive of this group for CMV lytic replication. Thus
they may serve as a viral CNS amplification reservoir
that could greatly enhance CMV dissemination into the
brain. In addition, a proinflammatory cytokine cascade
was expressed by brain pericytes following SBCMV infec-
tion for 72 hours. This included upregulation of chemo-
tactic cytokines CCL5/Rantes, I-TAC/CXCL11, and IL-8/
CXCL8, as well as IL1-beta and IL-6 with no induction of
TNF-alpha (Figure 4) which correlates with our semi-
quantitative ELISA assay (Figure 7A). These cytokines are
mainly chemotactic for neutrophils, T cells, basophils and
eosinophils and would serve to contribute to neuroinflam-
mation at the blood–brain barrier (Table 1).
Studies that demonstrate CMV infection of astrocytes
report the production of chemokines, mainly CCL2 and
cytokine transforming growth factor beta (TGF-beta)
[42,43]. In these studies, none of the proinflammatory
cytokines used (TNF-alpha, IL-1beta, and IL-6) were
found to be induced in astrocytes in a mouse model sys-
tem using murine cytomegalovirus (MCMV) [42]. Using
a low-passaged clinical isolate of HCMV (SBCMV) to
infect a commercial source of primary human astrocytes
at a low multiplicity of infection, we found no clear evi-
dence of CMV infection in these cells after 72 hours in
culture and by qPCR amplification (Figures 6 and 7).
There are in vitro reports (using laboratory-adapted
strains of CMV in human, murine and nonhuman pri-
mate model systems) that CMV infects both BMVEC
and astrocytes [42-45]. However our study, using a low
multiplicity of infection with a primary clinical HCMV
isolate obtained from a child with disseminated CMV
disease, found no evidence of CMV pp65 message above
background in infected BMVEC or astrocytes for up to
96 hours after infection when compared to pericytes
(Figure 6). The Towne strain of HCMV has been highly
passaged in culture and has accumulated multiple muta-
tions and deletion and is expected to have broader trop-
ism when compared to a low-passaged primary clinical
CMV isolate. The HCMV infections we performed were
IHC HIV/gag M1 400X IHC brain CMV MIE 400X
IHC brain CMV MIE 100XIHC HIV/gag M1 200X
IHC brain NG2-P/HCMV MIE







Figure 8 Immunohistochemical staining of HIV and CMV coinfected brain tissue. IHC staining of archival human hippocampus brain tissue
coinfected with HCMV from an HIV-infected patient. (A/B) Brain tissue IHC-stained for HIV Gag) using True Blue (Kirkegaard & Perry Laboratories,
Gaithersburg, MD, USA) as a substrate for immunoperoxidase. Photographs in A and B were taken at 200x and 400x magnification, respectively.
(D/C) IHC-stained brain tissue for the HCMV MIE gene protein using True Blue as an immunoperoxidase substrate. Photographs were at 200x and
400x magnification. (E) Brain tissue IHC dual-stained for the pericyte marker NG2 proteogylcan using 3,3-diaminobenzidine (DAB) staining cells
brown and CMV MIE gene protein using Vector Red (Vector Laboratories, Burlingame, CA, USA) as a substrate for alkaline phosphatase (dual-
stained indicated by arrows). This photograph was taken at 200x magnification. (F) Brain tissue dual-stained by IHC for NG2 proteoglycan and
HCMV MIE gene protein showing a cell with a brown-colored cytoplasm and a red nucleus. This image was taken at 600x magnification. All
images were taken with a Nikon TE2000S microscope fitted with a CCD camera (Nikon, Tokyo, Japan). CMV, cytomegalovirus; DAB, 3,3-
diaminobenzidine; IHC, immunohistochemistry; HCMV, human cytomegalovirus; MIE, major immediate early protein; NG2, neuron-glial antigen 2.
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at a low MOI and we monitored cytopathic effects after
72 hours in Figure 5 and, using mRNA from the same
cultures, we looked for pp65 late transcripts at 24 and
96 hours postinfection, which allows time for productive
infection (late gene expression). The infection was per-
formed at low MOI using a primary HCMV isolate, a
24- and 96-hour time point postinfection, and amplifica-
tion of the late protein pp65 transcripts likely contributed
to the low level of productive infection seen in astrocytes.
We observe that longer time periods postinfection, a
higher MOI, and the use of a laboratory-adapted strain of
virus will produce higher levels of productive infection in
fibroblasts and pericytes. Even more, we observed that
SBCMV-infected pericytes elicited higher levels of IL-6
when compared to mock-infected or heat-killed SBCMV
controls. Marginal increases in TNF-alpha levels were
observed in pericyte cultures exposed to both SBCMV
and heat-killed virus for 24 hours (Figure 7A), while no
change was observed in TGF-beta levels in virus-exposed
cells compared to uninfected control cells over this time
period. Increased levels of IL-6 and no induction of TNF-
alpha were observed in SBCMV-infected pericyte super-
natants at 24 hours postinfection. As we were not able to
obtain archival brain tissue from newborns that were only
CMV infected, we utilized CMV-infected brain tissue
from a patient coinfected with HIV. Because CMV is a la-
tent opportunistic pathogen that undergoes reactivation
Table 1 Microarray results three days after SBCMV
infection of brain vascular pericytes representing the







RSAD2 390 Protein directly induced by cytomegalovirus
ISG20 380 Interferon-stimulated exonuclease
CCL5 364 Chemotactic cytokine for activated T cells,
eosinophils and basophils
CXCL11 337 Chemotactic cytokine for activated T cells
CCL5 141 Chemotactic cytokine for activated T cells,
eosinophils and basophils
IFI27 117 Interferon alpha inducible gene/
inflammation
TAC1 111 Neurotransmitter, induction of behavioral
responses
CCL20 76 Chemotactic cytokine for lymphocytes and
neutrophils
HERC5 60 Interferon-induced ubiquitin-E3 protein
ligase
IL8 4 Chemotactic cytokine for neutrophils
CCL5, C chemokine (C-C motif) ligand 5; CCL20, chemokine (C-C motif) ligand
20; CXCL11, chemokine (C-X-C motif) ligand 11; HERC5, probable E3
ubiquitin-protein ligase HERC5; IFI27, interferon alpha-inducible protein 2; IL8,
interleukin 8; ISG20, interferon-stimulated gene 20 kDa protein; RSAD2, radical






















Figure 9 Model of HCMV dissemination across the blood–brain barrier including pericytes and a CMV-elicited proinflammatory
cytokine cascade. A working model of HCMV dissemination across the blood–brain barrier involving pericytes and a proinflammatory cytokine
cascade. (H)CMV, (human) cytomegalovirus.
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from latency in individuals that are immune-compromised,
HIV-infected patients can develop CMV neuropathology
[46-49]. Using HIV-CMV-infected archival human brain
tissue, we demonstrated CMV infection of brain pericytes
using dual-labeled IHC. We observed both HIV-positive
cells in this hippocampal tissue as well as CMV cytomegalic
cells with a characteristic CMV MIE nuclear staining
pattern. In addition, we demonstrated brain cells staining
positive for the pericyte marker NG2 proteoglycan, which
co-stained for HCMV MIE gene protein, suggesting that
pericytes support CMV infection in vivo (Figure 8). We
realize that no specific pericyte marker has been identified.
The use of alpha smooth muscle actin (alpha-SMA) has
been employed by investigators to identify pericytes in situ,
however in the brain, only pericytes located near arterioles
routinely stain positive for alpha-SMA. In primary cultures,
only 5% of newly isolated capillary pericytes stain positive
for this marker [22]. Studies by Ozerdem et al. [28] sug-
gested that NG2 proteogylcan is expressed exclusively by
pericytes (mural cells) during vascular morphogenesis.
With this reasoning we used NG2 proteogylcan as a marker
for pericytes in our IHC experiments.
Conclusion
Based in part on these findings, we proposed a model of
HCMV dissemination from the blood across the BBB
into the brain (Figure 9). As HCMV traffics into the
brain, the virus encounters brain microvascular endothe-
lial cells that may be marginally permissive for infection
[50,51]. HCMV-infected blood monocytes may also gain
access to the brain via chemotactic factors like monocyte
chemotactic protein 1 (MCP-1) [52]. Cell-free virus could
also gain access to the brain via pinocytosis or paracellular
transport between brain microvascular endothelial cells
(Figure 9). All routes require HCMV to interact with peri-
cytes. Therefore we propose that brain vascular pericytes
serve as a virus amplification reservoir at the BBB inter-
face and, upon infection, they express a proinflammatory
cytokine cascade that could result in increased inflamma-
tion and contribute to CMV neuropathology. HCMV
upregulation of proinflammatory cytokines IL-1beta, IL-6
and TNF-alpha in permissive cell has been extensively
studied. At early times postinfection, several studies have
shown HCMV activation of IL-1, TNF-alpha, nuclear fac-
tor-kappa B (NF-kB) and various mitogen activated
protein kinases (MAPKs) [53-57]. A second phase of acti-
vation occurs after virus entry, induced partly by the
major viral transcriptional activators IE1 and IE2, which
are thought to be required for initial virus replication.
Stimulation of IL-1 and TNF-alpha pathways may also
support viral dissemination via recruitment of permissive
cells, as a result of increased chemokine secretion such as
IL-8, IL-6, and Rantes [58-61]. More recent studies are be-
ginning to suggest the ability of HCMV to suppress IL-1
and TNF-alpha signaling pathways at different times after
infection [62,63]. However, the exact mechanisms involved
in HCMV regulation of proinflammatory signaling path-
ways will require further investigation. Taken together,
these studies suggest that as HCMV traffics the neu-
rovasculature, virus infection of pericytes is imminent,
resulting in infection amplification and the induction
of cytokines that heightens the inflammatory state of
the CNS microenvironment.
The model in Figure 9 indicates how HCMV might inter-
act with pericytes leading to several potential responses.
Infected blood monocytes could either extravasate between
BMVEC and transmit infection to pericytes via cell-to-cell
contact, or cell-free virus could pass between BMVEC via
paracellular transport, to directly infect pericytes. In sup-
port of this model, we find pericytes to be fully permissive
for HCMV infection. We also suggest that pericytes directly
serve as amplification sites for productive viral infection,
which would allow CMV to disseminate further into the
brain parenchyma.
CMV infection of pericytes would result in a cytokine
cascade that would serve to attract inflammatory cells such
as neutrophils, basophils and T cells that would in aggre-
gate contribute to neuroinflammation. Figure 9 represents
a summary of our findings and exemplifies a model of our
hypothesis with regard to HCMV interaction with cellular
components of the blood–brain barrier. We are aware that
a congenital infection occurs during prenatal life when the
blood–brain barrier is still very immature and leaky, allow-
ing more access of HCMV to the brain. Still these data are
provocative and require investigators to take a closer look
at the role of pericytes in this process.
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